Furthermore, since basic research showed that OPN contributes to the development of nephropathy and atherosclerosis in diabetes [10,18-20], inhibition of OPN may become a novel therapeutic strategy for these paitents. This evidence concerns the gene SPP1 and atherosclerosis.